ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "Tetravac" (21)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
(Codice) 11 products   
  IPCI Ebvallo PRPRk.A.Pierre Fabre Pharma SAAGtell a friend
L IP  Vegzelma 100 mg/4 ml 257.57296.5510 %Concentrate for infusion: Bevacizumabum 100mg / 4mliQone Healthcare
Switzerland SA
A / SLGtell a friend
L IP  Vegzelma 400 mg/16 ml 962.841063.5510 %Concentrate for infusion: Bevacizumabum 400mg / 16mliQone Healthcare
Switzerland SA
A / SLGtell a friend
L IP PPHerceptin subkutan
600mg/5ml
 1484.041630.4010 %Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5mlRoche Pharma
(Schweiz) AG
A / SLGtell a friend
L IP  Ogivri 150 mg 456.84513.2510 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mgMedius AGA / SLGtell a friend
  IPCI Bilaxten 6 mg / ml5 mlPRPRk.A.Eye drops: Bilastinum 6 mg/mlA. Menarini GmbHBGtell a friend
  IPCI Regaine 2 %60 mlPRPRk.A.Solution: Minoxidilum 20 mg/mlJNTL Consumer Health II
(Switzerland) GmbH
D / LPPVGtell a friend
  IPCI Regaine 2 %3 x 60 mlPRPRk.A.Solution: Minoxidilum 20 mg/mlJNTL Consumer Health II
(Switzerland) GmbH
D / LPPVGtell a friend
  IPCI Regaine 5 %60 mlPRPRk.A.Solution: Minoxidilum 50 mg/mlJNTL Consumer Health II
(Switzerland) GmbH
D / LPPVGtell a friend
  IPCI Regaine 5 %3 x 60 mlPRPRk.A.Solution: Minoxidilum 50 mg/mlJNTL Consumer Health II
(Switzerland) GmbH
D / LPPVGtell a friend
  IP  Mylotarg 5 mg PRPRk.A.Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mgPfizer AGAGtell a friend
Diphtheria-Pertussis-Poliomyelitis-Tetanus (J07CA02) 10 products WHO-DDD DrugBank.ca 
L IP V/SBoostrix Polio 24.8643.4510 %4 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
L IP V/SInfanrix DTPa-IPV 20.2038.4010 %8 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
L IP V/STetravac 20.2138.4010 %Injection suspension: 2 Active AgentsSanofi-Aventis
(Suisse) SA
B / SLGtell a friend
  IP V/SBoostrix Polio10PRPRk.A.4 Active AgentsGlaxoSmithKline AGBGtell a friend
L IP V/SAdacel-Polio 0.5 ml0.5 ml24.0042.5010 %Sanofi-Aventis
(Suisse) SA
B / SLGtell a friend
  IP V/SAdacel-Polio 0.5 ml0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA
BGtell a friend
  IP V/SAdacel-Polio 0.5 ml0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA
BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA
BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA
BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA
BGtell a friend
 show caption
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home